Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Chih‐Chen Hong"'
Autor:
Kuei-Min Chung, Ya-Ting Chen, Chih-Chen Hong, Il-Chi Chang, Si-Ying Lin, Li-Yu Liang, Yi-Rong Chen, Chau-Ting Yeh, Shiu-Feng Huang
Publikováno v:
Biochemistry and Biophysics Reports, Vol 31, Iss , Pp 101303- (2022)
Hepatocellular carcinoma (HCC) is the main threat for the patients infected with hepatitis B virus (HBV), but the oncogenic mechanism of HBV-related HCC is still controversial. Previously, we have found that several HBV surface gene (HBS) non-sense m
Externí odkaz:
https://doaj.org/article/3323f4ea14ca48028794cf0c9efb7f72
Autor:
Hui‐Huang Lai, Chih‐Wei Li, Chih‐Chen Hong, Hung‐Yu Sun, Ching‐Feng Chiu, Da‐Liang Ou, Pai‐Sheng Chen
Publikováno v:
Molecular Oncology, Vol 13, Iss 4, Pp 928-945 (2019)
Hepatocellular carcinoma (HCC) is a lethal human malignancy and a leading cause of cancer‐related death worldwide. Patients with HCC are often diagnosed at an advanced stage, and the prognosis is usually poor. The multikinase inhibitor sorafenib is
Externí odkaz:
https://doaj.org/article/930d5ccc72814ecf8d2a8f7129a23b8b
Autor:
Chih-Chen Hong, 洪志成
96
Drug resistance is the primary cause of leukemia chemotherapy failure. Although numerous mechanisms of drug resistance have been described, it is still not fully understood at present. Analysis of genes differentially expressed in the sensiti
Drug resistance is the primary cause of leukemia chemotherapy failure. Although numerous mechanisms of drug resistance have been described, it is still not fully understood at present. Analysis of genes differentially expressed in the sensiti
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/16346370898159883619
Autor:
Shuang-En Chuang, Ih-Jen Su, Ann-Lii Cheng, Gi-Ming Lai, Yi-Pin Lai, Ching-Hang Liu, Chung-Yi Pao, Ya-Yu Yang, Jhy-Shrian Huang, Chih-Chen Hong, Jong-Ding Lay
Metastasis and drug resistance are the major causes of mortality in patients with non–small cell lung cancer (NSCLC). Several receptor tyrosine kinases (RTKs), including AXL, are involved in the progression of NSCLC. The AXL/MER/SKY subfamily is in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c40190aeab6c7f68a01bcff05840fb
https://doi.org/10.1158/0008-5472.c.6495858.v1
https://doi.org/10.1158/0008-5472.c.6495858.v1
Autor:
Shuang-En Chuang, Ih-Jen Su, Ann-Lii Cheng, Gi-Ming Lai, Yi-Pin Lai, Ching-Hang Liu, Chung-Yi Pao, Ya-Yu Yang, Jhy-Shrian Huang, Chih-Chen Hong, Jong-Ding Lay
Supplementary Figures 1-6 from Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6174ebad8430f6a5009c837d2d049a22
https://doi.org/10.1158/0008-5472.22368222.v1
https://doi.org/10.1158/0008-5472.22368222.v1
Autor:
Jen-Liang Su, Nan-Yung Hsu, Shine-Gwo Shiah, Nai-Wen Hsu, Mien-Chie Hung, Yang-Hao Yu, Yi-Wen Chang, Michael Hsiao, Ching-Yao Yang, Ching-Feng Chiu, Jean Chiou, Pai-Sheng Chen, Chih-Chen Hong
Supplementary Figure 4. The mRNA expression of miR-326 in TE-8 cells with knockdown of VEGFR-3. TE-8 cells were transiently transfected shVEGFR-3#1, #2 or shCtrl for 48 hours and isolated total RNA to assay. A, qRT-PCR was used to quantify the expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95100c2c20ed2f2a8e390048b5d2cc72
https://doi.org/10.1158/0008-5472.22403088
https://doi.org/10.1158/0008-5472.22403088
Autor:
Jen-Liang Su, Nan-Yung Hsu, Shine-Gwo Shiah, Nai-Wen Hsu, Mien-Chie Hung, Yang-Hao Yu, Yi-Wen Chang, Michael Hsiao, Ching-Yao Yang, Ching-Feng Chiu, Jean Chiou, Pai-Sheng Chen, Chih-Chen Hong
Supplementary Figure 5. The mRNA expression of Dicer between TE-1/VEGF-C and TE-1/vector cells. TE-1 cells were stably expressed VEGF-C or vector control and isolated total RNA to assay. qRT-PCR was used to quantify the expression level of Dicer, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d51f73dcd22bb0ad1073cf34ad75b034
https://doi.org/10.1158/0008-5472.22403085
https://doi.org/10.1158/0008-5472.22403085
Autor:
Jen-Liang Su, Nan-Yung Hsu, Shine-Gwo Shiah, Nai-Wen Hsu, Mien-Chie Hung, Yang-Hao Yu, Yi-Wen Chang, Michael Hsiao, Ching-Yao Yang, Ching-Feng Chiu, Jean Chiou, Pai-Sheng Chen, Chih-Chen Hong
Supplementary Figure 2. The phosphorylated VEGFR-3 in TE-1 cells with VEGF-C and VEGF-A treatment. TE-1 cells were starved with serum-free medium for 16 hours and treated with 100 and 200 ng/mL VEGF-C as well as 200 ng/mL VEGF-A for 10 minutes, follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b054b8d5953242731c92e6476014639
https://doi.org/10.1158/0008-5472.22403094.v1
https://doi.org/10.1158/0008-5472.22403094.v1
Autor:
Hung Yu Sun, Hui Huang Lai, Chih Wei Li, Ching Feng Chiu, Pai Sheng Chen, Chih Chen Hong, Da-Liang Ou
Publikováno v:
Molecular Oncology, Vol 13, Iss 4, Pp 928-945 (2019)
Molecular Oncology
Molecular Oncology
Hepatocellular carcinoma (HCC) is a lethal human malignancy and a leading cause of cancer‐related death worldwide. Patients with HCC are often diagnosed at an advanced stage, and the prognosis is usually poor. The multikinase inhibitor sorafenib is
Autor:
Cheng-Chung Tsai, Chih-Chen Hong, Yung-Ming Jeng, Shiu-Feng Huang, Il-Chi Chang, Cheng-Chung Wu, Hock-Liew Eng, Chao-Long Chen, Ming-Chih Ho, John Wang, Chi-Ling Chen, Hui-Hwa Tseng, Ying-Ying Shen, Tseng-Chang Yen, Yun-Fan Liaw, Hsien-Chung Yu, Chau-Ting Yeh, Wei-Chen Lee, Pei-Jer Chen
Publikováno v:
Hepatology Communications
Metabolic risk factors, such as obesity, fatty liver, high lipidemia, and diabetes mellitus are associated with increased risk for nonviral hepatocellular carcinoma (HCC); however, few nonviral HCC studies have stratified patients according to underl